Type Of Study Population Treatment Variable Result Year Type

type of study population treatment variable result year type of neoplasia index chappidi, et al. [8] retrospect

Type of Study
Population
Treatment
Variable
Result
Year
Type of Neoplasia
Index
Chappidi, et al. [8]
Retrospective
2679
Surgery
Mortality (one month)
mFI > 3 OR 2.07
95%CI: 0.78-5.49
p > 0.01
2016
Urologic
Modified Frailty Index from the Canadian Study on Health and Aging
Frailty Index
Buettner, et al. [9]
Prospective
1326
Surgery
Mortality
mFI score assessed at the time of initial surgery was not associated
with 1-year mortality
2015
Digestive
Modified Frailty Index from the Canadian Study on Health and Aging
Frailty Index and sarcopenia
Ugolini, et al. [10]
Prospective
46
Surgery
Mortality
TUGt OR 3.507,
95%CI: 1.35-9.11, p = 0.01
GFI was not associated with mortality
2015
Digestive
Timed up-and-go test and Groningen Frailty Index
Brown, et al. [11]
Prospective
416
Any kind of treatment
Mortality
Prefrail HR = 1.84
95%CI 1.28-2.65
p > 0.01
Frail HR 2.79,
95%CI: 1.34-5.81, p < 0.01
2015
Non-skin
Frailty Index
Aaldriks, et al. [12]
Prospective
520
Chemotherapy
Mortality
HR 1.47
95%CI 1.19-0.182
p < 0.001
2015
Any type of cancer
Groningen Frailty Index
Lascano, et al. [13]
Retrospective
41681
Surgery
Mortality (one month)
OR 5.95,
95%CI: 3.72-9.51, p < 0.01
2015
Urologic
Canadian Study on Health and Aging Frailty Index
Revening, et al. [14]
Prospective
393
Surgery
Mortality (one month)
Non frail OR 0.4
(not 95%CI) vs. frail OR 5.2 (not 95%CI)
p = 0.07
2015
Any type of cancer
Modified Frailty Index from the Canadian Study on Health and Aging
Frailty Index and sarcopenia
Bras, et al. [15]
Retrospective
90
Surgery
Mortality
GFI store didn´t predict significantly death. p = 0.265
2015
Head, neck and skin
Groningen Frailty Index
Uppal, et al. [16]
Retrospective
6551
Any kind of treatment
Mortality and morbidity
OR mFI > 4 = 12.5
95%CI = 4.77-32.76
p > 0.01
2015
Ginecologic
Modified Frailty Index from the Canadian Study on Health and Aging
Frailty Index
Handforth, et al. [17]
Retrospective (revisión)
2196
Any kind of treatment
Mortality
Prefrail HR 2.67,
95%CI 1.08-6.62;
Frail HR 2.33,
95%CI 1.20-4.52
2015
Any
Various (phenotype, cumulative déficit, comprehensive geriatric
assesment)
Morbidity
4.86,
95% CI 2.19-10.78
Aaldriks, et al. [18]
Prospective
90
Chemotherapy
Mortality
OR 2.55,
95%CI: 1.07-6.10; p = 0.04
2015
Lymphoma
Groningen Frailty Index
Response to treatment
9.17,
95% CI: 1.51-55.8; p = 0.02
Tegels, et al. [19]
Prospective
180
Surgery
Mortality
OR 4.0,
95%CI 1.1-14.1, p = 0.03
2014
Digestive (gastric)
Groningen Frailty Index
Dale, et al. [20]
Prospective
76
Surgery
Major complication or mortality
OR 4.06; p = 0.01
2014
Digestive (pancreatic)
Modified Frailty Index and Short Physical Performance Battery
ICU admission
OR = 4.30; p = 0.01
Aaldriks, et al. [21]
Prospective
143
Chemotherapy
Mortality
HR = 2.72
95% CI: 1.58-4.69; p < 0.001
2014
Digestive (colorectal)
Groningen Frailty Index
Aaldriks, et al. [22]
Prospective
55
Chemotherapy
Mortality
3.40
95% CI: 1.62-7.10; p = 0.001
2013
Breast
Groningen Frailty Index
Table 1: Studies selected and its principal characteristics.